Abstract
This study was performed to test whether monocrotaline (MCT)-induced early airway dysfunction and gas exchange abnormalities result in arterial hypoxemia. Thirty young male Sprague-Dawley rats were divided into four groups: control, MCT1, MCT2, and MCT3. Each of the control animals was injected (subcutaneously) with saline; each of the MCT rats was injected with MCT (60 mg/kg, subcutaneously). The rats were tested 1 (MCT1), 2 (MCT2), or 3 (MCT3) weeks after MCT injection. Two days before each animal was tested, it was anesthetized with sodium pentobarbital, and its carotid artery was chronically cannulated. Blood was sampled from the arterial catheter of the conscious rat, and blood gases and pH were measured. Pulmonary arterial pressure (Ppa) was determined in the anesthetized, open chest animal. Heart weight was measured and a weight ratio obtained of right ventricle (RV) to left ventricle plus septum (LV+S). The amount of lung substance P and airway neutral endopeptidase (NEP) activity were also measured. MCT significantly decreased arterial oxygen tension (Pao2) and increased the RV/(LV+S) weight ratio 2 and 3 weeks after administration, whereas it did not significantly increase Ppa until 3 weeks after injection. MCT significantly increased lung substance P levels and decreased airway NEP activities 1–3 weeks after administration. These data suggest that tachykinins cause hypoxemia and RV hypertrophy: then hypoxia may augment the development of pulmonary hypertension.
Similar content being viewed by others
References
Bloomquist EI, Kream RM (1990) Release of substance P from guinea pig trachea by leukotriene D4. Exp Lung Res 16:645–659
Borson DB (1991) Roles of neutral endopeptidase in airways. Am J Physiol 260:L212-L225
Christian EP, Taylor GE, Weinreich D (1989) Serotonin increases excitability of rabbit C-fiber neurons by two distinct mechanisms. J Appl Physiol 67:584–591
Colice GL, Lee YJ, Du HK, On LC (1994) Susceptibility to monocrotaline (MCT) and high altitude (HA) induced pulmonary hypertension varies in rat strains (abstract). FASEB J 8:A553
Foreman JC, Jordan CC (1984) Neurogenic inflammation. Trends Pharmacol Sci 5:116–119
Gillespie MN, Frederick WB, Altiere RJ, Olson JW, Kimmel EC (1985) Pulmonary mechanical, ventilatory, and gas exchange abnormalities in rats with monocrotaline-induced pulmonary hypertension. Exp Lung Res 8:191–199
Haxhiu-Poskurica B, Haxhiu MA, Kumar GK, Miller MJ, Martin RJ (1992) Tracheal smooth muscle responses to substance P and neurokinin A in the piglet. J Appl Physiol 72:1090–1095
Hill NS, Jederlinic P, Gagnon J (1989) Supplemental oxygen reduces right ventricular hypertrophy in monocrotaline-injected rats. J Appl Physiol 66:1642–1648
Kahler CM, Herold M, Wiedermann CJ (1993) Substance P: a competence factor for human fibroblast proliferation that induces the release of growth-regulatory arachidonic acid metabolites. J Cell Physiol 156:579–587
Kawaguchi AT, Kawashima Y, Ishibashi-Ueda H, Yanase M, Murakami T, Yagihara T, Kunieda T (1993) Right-to-left interatrial shunt in rats with progressive pulmonary hypertension. J Thorac Cardiovase Surg 106:1072–1080
Lai Y-L, Lamm WJE, Hildebrandt J (1981) Ventilation during prolonged hypercapnia in the rat. J Appl Physiol 51:78–83
Lai Y-L, Olson JW, Gillespie MN (1991) Ventilatory dysfunction precedes pulmonary vascular changes in monocrotaline-treated rats. J Appl Physiol 70:561–566
Lindefors N, Yamamoto Y, Pantaleo T, Lagercrantz H, Brodin E, Ungerstedt U (1986) In vivo release of substance P in nucleus tractus solitarii increases during hypoxia. Neurosci Lett 69:94–97
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275
McCormack DG, Rees RG, Crawley D, Barnes PJ, Evans TW (1993) Sensory neuropeptides and hypoxic pulmonary vasoconstriction in the rat. Thorax 48:554–557
Nilsson J, von Euler AM, Dalsgaard C-J (1985) Stimulation of connective tissue cell growth by substance P and substance K. Nature 315:61–63
Ollerenshaw SL, Jarvis D, Sullivan CE, Woolcock AJ (1991) Substance P immunoreactive nerves in airways from asthmatics and nonasthmatics. Eur Respir J 4:673–682
Olson JW, Hacker AD, Altiere RJ, Gillespie MN (1984) Polyamines and the development of monocrotaline-induced pulmonary hypertension. Am J Physiol 247:H682-H685
Orlowski M, Wilk S (1981) Purification and specificity of a membrane-bound metal loendopeptidase from bovine pituitary. Biochemistry 20:4942–4950
Otsuka M, Yoshika K (1993) Neurotransmitter functions of mammalian tachykinins. Physiol Rev 73:229–308
Paintal AS (1969) Mechanism of stimulation of type J pulmonary receptors. J Physiol 203:511–532
Rabinovitch M, Gamble W, Nadas AS, Miettinen OS, Reid L (1979) Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. Am J Physiol 236:H818-H827
Roth RA, Ganey PE (1988) Platelets and the puzzles of pulmonary pyrrolizidine poisoning. Toxicol Appl Pharmacol 93:463–471
Saria A, Martling C-R, Yan Z, Theodorsson-Norheim E, Gamse R, Lundberg JM (1988) Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, dimethylphenyl piperazinium, and vagal nerve stimulation. Am Rev Respir Dis 137:1330–1335
Shiao R-T, Kostenbauder HB, Olson JW, Gillespie MN (1990) Mechanisms of lung polyamine accumulation in chronic hypoxic pulmonary hypertension. Am J Physiol 259:L351-L358
Stenmark KR, Morganroth ML, Remigio LK, Voelkel NF, Murphy RC, Henson PM, Mathias MM, Reeves JT (1985) Alveolar inflammation and arachidonate metabolism in monocrotaline-induced pulmonary hypertension. Am J Physiol 248:H859-H866
Sugita T, Hyers TM, Dauber IM, Wagner WW, McMurtry IF, Reeves JT (1983) Lung vessel leak precedes right ventricular hypertrophy in monocrotaline-treated rats. J Appl Physiol 54:371–374
Tai H-H (1992) Enzyme immunoassay. In: Swarbrick J, Boylan JC (eds) Encyclopedia of Pharmaceutical Technology. vol 5, Dekker, New York. pp 201–233
Tanaka DT, Grunstein MM (1985) Vasoactive effects of substance P on isolated rabbit pulmonary artery. J Appl Physiol 58:1291–1297
Valdivia E, Lalich JJ, Hayashi Y, Sonnad J (1967) Alterations in pulmonary alveoli after a single injection of monocrotaline. Arch Pathol 84:64–76
Walker PD, Riley LA, Hart RP, Jonakait GM (1991) Serotonin regulation of tachykinin biosynthesis in the rat neostriatum. Brain Res 546:33–39
Whalen WJ, Buerk D, Thuning C, Kanoy BE Jr, Duran WN (1975) Tissue Po2 Vo2 venous Po2 and perfusion pressure in resting dog gracilis muscle perfused at constant flow. In: Grote J, Reneau D, Thews G (ed) Oxygen Transport to Tissue, II, Plenum Press, New York, pp 639–655
Wharton J, Polak JM, Bloom SR, Will JA, Brown MR, Pearse AGE (1979) Substance P-like immunoreactive nerves in mammalian lung. Invest Cell Pathol 2:3–10
Zhou K-R, Lai Y-L (1993) Capsaicin pretreatment attenuates monocrotaline-induced ventilatory dysfunction and pulmonary hypertension. J Appl Physiol 75:2781–2788
Author information
Authors and Affiliations
Additional information
Offprint requests to: Yih-Loong Lai
Rights and permissions
About this article
Cite this article
Lai, YL., Thacker, A.A. & Diana, J.N. Hypoxemia and elevated tachykinins in rat monocrotaline pneumotoxicity. Lung 174, 195–203 (1996). https://doi.org/10.1007/BF00173311
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00173311